Ifrah Financial Services’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,504
Closed -$205K 208
2023
Q3
$205K Buy
3,504
+30
+0.9% +$1.76K 0.06% 192
2023
Q2
$219K Buy
3,474
+106
+3% +$6.68K 0.07% 192
2023
Q1
$212K Buy
+3,368
New +$212K 0.07% 195
2022
Q3
Sell
-3,525
Closed -$255K 203
2022
Q2
$255K Sell
3,525
-60
-2% -$4.34K 0.08% 167
2022
Q1
$285K Sell
3,585
-6
-0.2% -$477 0.08% 172
2021
Q4
$363K Sell
3,591
-12
-0.3% -$1.21K 0.1% 150
2021
Q3
$332K Buy
3,603
+96
+3% +$8.85K 0.1% 150
2021
Q2
$359K Buy
3,507
+91
+3% +$9.32K 0.1% 149
2021
Q1
$333K Sell
3,416
-29
-0.8% -$2.83K 0.1% 152
2020
Q4
$266K Sell
3,445
-891
-21% -$68.8K 0.09% 161
2020
Q3
$319K Buy
4,336
+213
+5% +$15.7K 0.11% 134
2020
Q2
$303K Buy
4,123
+157
+4% +$11.5K 0.11% 141
2020
Q1
$229K Buy
3,966
+45
+1% +$2.6K 0.1% 144
2019
Q4
$308K Sell
3,921
-118
-3% -$9.27K 0.11% 140
2019
Q3
$276K Sell
4,039
-697
-15% -$47.6K 0.1% 141
2019
Q2
$376K Buy
4,736
+155
+3% +$12.3K 0.14% 125
2019
Q1
$384K Buy
4,581
+201
+5% +$16.8K 0.15% 123
2018
Q4
$516K Sell
4,380
-131
-3% -$15.4K 0.22% 87
2018
Q3
$544K Sell
4,511
-34
-0.7% -$4.1K 0.19% 102
2018
Q2
$524K Buy
4,545
+30
+0.7% +$3.46K 0.19% 100
2018
Q1
$388K Buy
4,515
+766
+20% +$65.8K 0.14% 134
2017
Q4
$278K Buy
+3,749
New +$278K 0.1% 160
2017
Q3
Sell
-3,481
Closed -$223K 208
2017
Q2
$223K Sell
3,481
-105
-3% -$6.73K 0.09% 172
2017
Q1
$207K Sell
3,586
-1,516
-30% -$87.5K 0.08% 176
2016
Q4
$312K Sell
5,102
-188
-4% -$11.5K 0.13% 148
2016
Q3
$366K Buy
5,290
+444
+9% +$30.7K 0.15% 129
2016
Q2
$270K Sell
4,846
-3,186
-40% -$178K 0.11% 151
2016
Q1
$488K Sell
8,032
-274
-3% -$16.6K 0.19% 89
2015
Q4
$531K Sell
8,306
-54
-0.6% -$3.45K 0.21% 92
2015
Q3
$560K Sell
8,360
-42
-0.5% -$2.81K 0.23% 85
2015
Q2
$574K Sell
8,402
-148
-2% -$10.1K 0.21% 90
2015
Q1
$475K Sell
8,550
-30
-0.3% -$1.67K 0.18% 102
2014
Q4
$440K Sell
8,580
-502
-6% -$25.7K 0.17% 107
2014
Q3
$334K Sell
9,082
-96
-1% -$3.53K 0.13% 132
2014
Q2
$359K Buy
+9,178
New +$359K 0.14% 126